JP2019522459A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019522459A5 JP2019522459A5 JP2018554100A JP2018554100A JP2019522459A5 JP 2019522459 A5 JP2019522459 A5 JP 2019522459A5 JP 2018554100 A JP2018554100 A JP 2018554100A JP 2018554100 A JP2018554100 A JP 2018554100A JP 2019522459 A5 JP2019522459 A5 JP 2019522459A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- cdr
- polypeptide chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 641
- 229920001184 polypeptide Polymers 0.000 claims 121
- 102000004196 processed proteins & peptides Human genes 0.000 claims 121
- 108090000765 processed proteins & peptides Proteins 0.000 claims 121
- 102000014914 Carrier Proteins Human genes 0.000 claims 65
- 108091008324 binding proteins Proteins 0.000 claims 65
- 239000000427 antigen Substances 0.000 claims 40
- 102000036639 antigens Human genes 0.000 claims 40
- 108091007433 antigens Proteins 0.000 claims 40
- -1 CCL17 Proteins 0.000 claims 38
- 238000006467 substitution reaction Methods 0.000 claims 29
- 102000004169 proteins and genes Human genes 0.000 claims 26
- 108090000623 proteins and genes Proteins 0.000 claims 26
- 102100027207 CD27 antigen Human genes 0.000 claims 15
- 101000914511 Homo sapiens CD27 antigen Proteins 0.000 claims 15
- 102100029722 Ectonucleoside triphosphate diphosphohydrolase 1 Human genes 0.000 claims 13
- 150000001413 amino acids Chemical class 0.000 claims 13
- 101001012447 Homo sapiens Ectonucleoside triphosphate diphosphohydrolase 1 Proteins 0.000 claims 12
- 239000008194 pharmaceutical composition Substances 0.000 claims 12
- 101000666896 Homo sapiens V-type immunoglobulin domain-containing suppressor of T-cell activation Proteins 0.000 claims 11
- 108700012920 TNF Proteins 0.000 claims 11
- 102100038282 V-type immunoglobulin domain-containing suppressor of T-cell activation Human genes 0.000 claims 11
- 101001019455 Homo sapiens ICOS ligand Proteins 0.000 claims 9
- 101001002634 Homo sapiens Interleukin-1 alpha Proteins 0.000 claims 9
- 102100034980 ICOS ligand Human genes 0.000 claims 9
- 102100020881 Interleukin-1 alpha Human genes 0.000 claims 9
- 206010028980 Neoplasm Diseases 0.000 claims 9
- 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 claims 8
- 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 claims 8
- 238000000034 method Methods 0.000 claims 8
- 101100286681 Homo sapiens IL13 gene Proteins 0.000 claims 7
- 101001002709 Homo sapiens Interleukin-4 Proteins 0.000 claims 7
- 102000055229 human IL4 Human genes 0.000 claims 7
- 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 claims 6
- 102100029822 B- and T-lymphocyte attenuator Human genes 0.000 claims 6
- 102100036846 C-C motif chemokine 21 Human genes 0.000 claims 6
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims 6
- 102100035943 HERV-H LTR-associating protein 2 Human genes 0.000 claims 6
- 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 claims 6
- 101000864344 Homo sapiens B- and T-lymphocyte attenuator Proteins 0.000 claims 6
- 101000713085 Homo sapiens C-C motif chemokine 21 Proteins 0.000 claims 6
- 101001021491 Homo sapiens HERV-H LTR-associating protein 2 Proteins 0.000 claims 6
- 101001117317 Homo sapiens Programmed cell death 1 ligand 1 Proteins 0.000 claims 6
- 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 claims 6
- 102100029527 Natural cytotoxicity triggering receptor 3 ligand 1 Human genes 0.000 claims 6
- 102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 claims 6
- 102100024213 Programmed cell death 1 ligand 2 Human genes 0.000 claims 6
- 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 claims 6
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims 5
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims 5
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims 5
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims 5
- 108010009254 Lysosomal-Associated Membrane Protein 1 Proteins 0.000 claims 5
- 102100035133 Lysosome-associated membrane glycoprotein 1 Human genes 0.000 claims 5
- 210000001744 T-lymphocyte Anatomy 0.000 claims 5
- 210000004027 cell Anatomy 0.000 claims 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 4
- 108010047041 Complementarity Determining Regions Proteins 0.000 claims 4
- 101150029707 ERBB2 gene Proteins 0.000 claims 4
- 108060003951 Immunoglobulin Proteins 0.000 claims 4
- 102000013463 Immunoglobulin Light Chains Human genes 0.000 claims 4
- 108010065825 Immunoglobulin Light Chains Proteins 0.000 claims 4
- 108090000176 Interleukin-13 Proteins 0.000 claims 4
- 102000003816 Interleukin-13 Human genes 0.000 claims 4
- 102000004388 Interleukin-4 Human genes 0.000 claims 4
- 108090000978 Interleukin-4 Proteins 0.000 claims 4
- 102000004890 Interleukin-8 Human genes 0.000 claims 4
- 108090001007 Interleukin-8 Proteins 0.000 claims 4
- 102000000585 Interleukin-9 Human genes 0.000 claims 4
- 108010002335 Interleukin-9 Proteins 0.000 claims 4
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 4
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims 4
- 102000018358 immunoglobulin Human genes 0.000 claims 4
- BGFTWECWAICPDG-UHFFFAOYSA-N 2-[bis(4-chlorophenyl)methyl]-4-n-[3-[bis(4-chlorophenyl)methyl]-4-(dimethylamino)phenyl]-1-n,1-n-dimethylbenzene-1,4-diamine Chemical compound C1=C(C(C=2C=CC(Cl)=CC=2)C=2C=CC(Cl)=CC=2)C(N(C)C)=CC=C1NC(C=1)=CC=C(N(C)C)C=1C(C=1C=CC(Cl)=CC=1)C1=CC=C(Cl)C=C1 BGFTWECWAICPDG-UHFFFAOYSA-N 0.000 claims 3
- 101100339431 Arabidopsis thaliana HMGB2 gene Proteins 0.000 claims 3
- 208000032679 Autosomal recessive spastic paraplegia type 64 Diseases 0.000 claims 3
- 108010008014 B-Cell Maturation Antigen Proteins 0.000 claims 3
- 102000006942 B-Cell Maturation Antigen Human genes 0.000 claims 3
- 101000840545 Bacillus thuringiensis L-isoleucine-4-hydroxylase Proteins 0.000 claims 3
- 102100024167 C-C chemokine receptor type 3 Human genes 0.000 claims 3
- 101710149862 C-C chemokine receptor type 3 Proteins 0.000 claims 3
- 101710149863 C-C chemokine receptor type 4 Proteins 0.000 claims 3
- 102100023703 C-C motif chemokine 15 Human genes 0.000 claims 3
- 102100036842 C-C motif chemokine 19 Human genes 0.000 claims 3
- 102100036848 C-C motif chemokine 20 Human genes 0.000 claims 3
- 102100036849 C-C motif chemokine 24 Human genes 0.000 claims 3
- 102100021933 C-C motif chemokine 25 Human genes 0.000 claims 3
- 102100021935 C-C motif chemokine 26 Human genes 0.000 claims 3
- 102100032367 C-C motif chemokine 5 Human genes 0.000 claims 3
- 102100032366 C-C motif chemokine 7 Human genes 0.000 claims 3
- 102100034871 C-C motif chemokine 8 Human genes 0.000 claims 3
- 102100028990 C-X-C chemokine receptor type 3 Human genes 0.000 claims 3
- 102100025277 C-X-C motif chemokine 13 Human genes 0.000 claims 3
- 102100039521 C-type lectin domain family 9 member A Human genes 0.000 claims 3
- 102100032976 CCR4-NOT transcription complex subunit 6 Human genes 0.000 claims 3
- 102100024263 CD160 antigen Human genes 0.000 claims 3
- 102100038078 CD276 antigen Human genes 0.000 claims 3
- 101150013553 CD40 gene Proteins 0.000 claims 3
- 102100032937 CD40 ligand Human genes 0.000 claims 3
- 102100025221 CD70 antigen Human genes 0.000 claims 3
- 101100328097 Caenorhabditis elegans clec-91 gene Proteins 0.000 claims 3
- 108091007854 Cdh1/Fizzy-related Proteins 0.000 claims 3
- 102100035294 Chemokine XC receptor 1 Human genes 0.000 claims 3
- 102000012286 Chitinases Human genes 0.000 claims 3
- 108010022172 Chitinases Proteins 0.000 claims 3
- 102100038497 Cytokine receptor-like factor 2 Human genes 0.000 claims 3
- 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 claims 3
- 102100023688 Eotaxin Human genes 0.000 claims 3
- 102100040859 Fizzy-related protein homolog Human genes 0.000 claims 3
- 102100020997 Fractalkine Human genes 0.000 claims 3
- 108090000369 Glutamate Carboxypeptidase II Proteins 0.000 claims 3
- 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 claims 3
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 claims 3
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims 3
- 108700010013 HMGB1 Proteins 0.000 claims 3
- 101150021904 HMGB1 gene Proteins 0.000 claims 3
- 102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 claims 3
- 102100038006 High affinity immunoglobulin epsilon receptor subunit alpha Human genes 0.000 claims 3
- 102100037907 High mobility group protein B1 Human genes 0.000 claims 3
- 101000978376 Homo sapiens C-C motif chemokine 15 Proteins 0.000 claims 3
- 101000713106 Homo sapiens C-C motif chemokine 19 Proteins 0.000 claims 3
- 101000713099 Homo sapiens C-C motif chemokine 20 Proteins 0.000 claims 3
- 101000713078 Homo sapiens C-C motif chemokine 24 Proteins 0.000 claims 3
- 101000897486 Homo sapiens C-C motif chemokine 25 Proteins 0.000 claims 3
- 101000897493 Homo sapiens C-C motif chemokine 26 Proteins 0.000 claims 3
- 101000797762 Homo sapiens C-C motif chemokine 5 Proteins 0.000 claims 3
- 101000797758 Homo sapiens C-C motif chemokine 7 Proteins 0.000 claims 3
- 101000946794 Homo sapiens C-C motif chemokine 8 Proteins 0.000 claims 3
- 101000916050 Homo sapiens C-X-C chemokine receptor type 3 Proteins 0.000 claims 3
- 101000858064 Homo sapiens C-X-C motif chemokine 13 Proteins 0.000 claims 3
- 101000888548 Homo sapiens C-type lectin domain family 9 member A Proteins 0.000 claims 3
- 101000884279 Homo sapiens CD276 antigen Proteins 0.000 claims 3
- 101000934356 Homo sapiens CD70 antigen Proteins 0.000 claims 3
- 101000804783 Homo sapiens Chemokine XC receptor 1 Proteins 0.000 claims 3
- 101000956427 Homo sapiens Cytokine receptor-like factor 2 Proteins 0.000 claims 3
- 101000978392 Homo sapiens Eotaxin Proteins 0.000 claims 3
- 101000854520 Homo sapiens Fractalkine Proteins 0.000 claims 3
- 101001068133 Homo sapiens Hepatitis A virus cellular receptor 2 Proteins 0.000 claims 3
- 101000878611 Homo sapiens High affinity immunoglobulin epsilon receptor subunit alpha Proteins 0.000 claims 3
- 101001037256 Homo sapiens Indoleamine 2,3-dioxygenase 1 Proteins 0.000 claims 3
- 101001034652 Homo sapiens Insulin-like growth factor 1 receptor Proteins 0.000 claims 3
- 101001015006 Homo sapiens Integrin beta-4 Proteins 0.000 claims 3
- 101001076418 Homo sapiens Interleukin-1 receptor type 1 Proteins 0.000 claims 3
- 101000852968 Homo sapiens Interleukin-1 receptor-like 1 Proteins 0.000 claims 3
- 101000998146 Homo sapiens Interleukin-17A Proteins 0.000 claims 3
- 101001010626 Homo sapiens Interleukin-22 Proteins 0.000 claims 3
- 101000853002 Homo sapiens Interleukin-25 Proteins 0.000 claims 3
- 101000960936 Homo sapiens Interleukin-5 receptor subunit alpha Proteins 0.000 claims 3
- 101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 claims 3
- 101001137987 Homo sapiens Lymphocyte activation gene 3 protein Proteins 0.000 claims 3
- 101000628535 Homo sapiens Metalloreductase STEAP2 Proteins 0.000 claims 3
- 101001128431 Homo sapiens Myeloid-derived growth factor Proteins 0.000 claims 3
- 101100460850 Homo sapiens NCR3LG1 gene Proteins 0.000 claims 3
- 101001109501 Homo sapiens NKG2-D type II integral membrane protein Proteins 0.000 claims 3
- 101000633520 Homo sapiens Natural cytotoxicity triggering receptor 3 ligand 1 Proteins 0.000 claims 3
- 101100407307 Homo sapiens PDCD1LG2 gene Proteins 0.000 claims 3
- 101000611936 Homo sapiens Programmed cell death protein 1 Proteins 0.000 claims 3
- 101000610551 Homo sapiens Prominin-1 Proteins 0.000 claims 3
- 101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 claims 3
- 101000617130 Homo sapiens Stromal cell-derived factor 1 Proteins 0.000 claims 3
- 101000585365 Homo sapiens Sulfotransferase 2A1 Proteins 0.000 claims 3
- 101000831007 Homo sapiens T-cell immunoreceptor with Ig and ITIM domains Proteins 0.000 claims 3
- 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 claims 3
- 101000845170 Homo sapiens Thymic stromal lymphopoietin Proteins 0.000 claims 3
- 101000831567 Homo sapiens Toll-like receptor 2 Proteins 0.000 claims 3
- 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 claims 3
- 101000669460 Homo sapiens Toll-like receptor 5 Proteins 0.000 claims 3
- 101000795107 Homo sapiens Triggering receptor expressed on myeloid cells 1 Proteins 0.000 claims 3
- 101000638251 Homo sapiens Tumor necrosis factor ligand superfamily member 9 Proteins 0.000 claims 3
- 101000795167 Homo sapiens Tumor necrosis factor receptor superfamily member 13B Proteins 0.000 claims 3
- 101000795169 Homo sapiens Tumor necrosis factor receptor superfamily member 13C Proteins 0.000 claims 3
- 101000801234 Homo sapiens Tumor necrosis factor receptor superfamily member 18 Proteins 0.000 claims 3
- 101000864342 Homo sapiens Tyrosine-protein kinase BTK Proteins 0.000 claims 3
- 101001050476 Homo sapiens Tyrosine-protein kinase ITK/TSK Proteins 0.000 claims 3
- 101000955999 Homo sapiens V-set domain-containing T-cell activation inhibitor 1 Proteins 0.000 claims 3
- 102000026633 IL6 Human genes 0.000 claims 3
- 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 claims 3
- 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 claims 3
- 102100040061 Indoleamine 2,3-dioxygenase 1 Human genes 0.000 claims 3
- 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 claims 3
- 102100033000 Integrin beta-4 Human genes 0.000 claims 3
- 102100026016 Interleukin-1 receptor type 1 Human genes 0.000 claims 3
- 102000003814 Interleukin-10 Human genes 0.000 claims 3
- 108090000174 Interleukin-10 Proteins 0.000 claims 3
- 108010065805 Interleukin-12 Proteins 0.000 claims 3
- 102000013462 Interleukin-12 Human genes 0.000 claims 3
- 102000003812 Interleukin-15 Human genes 0.000 claims 3
- 108090000172 Interleukin-15 Proteins 0.000 claims 3
- 102100033461 Interleukin-17A Human genes 0.000 claims 3
- 102000003810 Interleukin-18 Human genes 0.000 claims 3
- 108090000171 Interleukin-18 Proteins 0.000 claims 3
- 102000000588 Interleukin-2 Human genes 0.000 claims 3
- 108010002350 Interleukin-2 Proteins 0.000 claims 3
- 102100026879 Interleukin-2 receptor subunit beta Human genes 0.000 claims 3
- 102100030703 Interleukin-22 Human genes 0.000 claims 3
- 108010065637 Interleukin-23 Proteins 0.000 claims 3
- 102000013264 Interleukin-23 Human genes 0.000 claims 3
- 102100036680 Interleukin-25 Human genes 0.000 claims 3
- 108010066979 Interleukin-27 Proteins 0.000 claims 3
- 102100036678 Interleukin-27 subunit alpha Human genes 0.000 claims 3
- 108010067003 Interleukin-33 Proteins 0.000 claims 3
- 102000017761 Interleukin-33 Human genes 0.000 claims 3
- 102000000743 Interleukin-5 Human genes 0.000 claims 3
- 108010002616 Interleukin-5 Proteins 0.000 claims 3
- 102100039881 Interleukin-5 receptor subunit alpha Human genes 0.000 claims 3
- 108090001005 Interleukin-6 Proteins 0.000 claims 3
- 102000000704 Interleukin-7 Human genes 0.000 claims 3
- 108010002586 Interleukin-7 Proteins 0.000 claims 3
- 102000002698 KIR Receptors Human genes 0.000 claims 3
- 108010043610 KIR Receptors Proteins 0.000 claims 3
- 102000017578 LAG3 Human genes 0.000 claims 3
- 102000016267 Leptin Human genes 0.000 claims 3
- 108010092277 Leptin Proteins 0.000 claims 3
- 102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 claims 3
- 102000043131 MHC class II family Human genes 0.000 claims 3
- 108091054438 MHC class II family Proteins 0.000 claims 3
- 101001043810 Macaca fascicularis Interleukin-7 receptor subunit alpha Proteins 0.000 claims 3
- 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 claims 3
- 102100028123 Macrophage colony-stimulating factor 1 Human genes 0.000 claims 3
- 108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 claims 3
- 102100026711 Metalloreductase STEAP2 Human genes 0.000 claims 3
- 101000597780 Mus musculus Tumor necrosis factor ligand superfamily member 18 Proteins 0.000 claims 3
- 102100022680 NKG2-D type II integral membrane protein Human genes 0.000 claims 3
- 108010042215 OX40 Ligand Proteins 0.000 claims 3
- 102100040678 Programmed cell death protein 1 Human genes 0.000 claims 3
- 102100040120 Prominin-1 Human genes 0.000 claims 3
- 108050000258 Prostaglandin D receptors Proteins 0.000 claims 3
- 102100024218 Prostaglandin D2 receptor 2 Human genes 0.000 claims 3
- 101001037255 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Indoleamine 2,3-dioxygenase Proteins 0.000 claims 3
- 102100038081 Signal transducer CD24 Human genes 0.000 claims 3
- 102100021669 Stromal cell-derived factor 1 Human genes 0.000 claims 3
- 102100029867 Sulfotransferase 2A1 Human genes 0.000 claims 3
- 102000000551 Syk Kinase Human genes 0.000 claims 3
- 108010016672 Syk Kinase Proteins 0.000 claims 3
- 102100024834 T-cell immunoreceptor with Ig and ITIM domains Human genes 0.000 claims 3
- 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 claims 3
- 102100031294 Thymic stromal lymphopoietin Human genes 0.000 claims 3
- 108010060818 Toll-Like Receptor 9 Proteins 0.000 claims 3
- 102000002689 Toll-like receptor Human genes 0.000 claims 3
- 108020000411 Toll-like receptor Proteins 0.000 claims 3
- 102100024333 Toll-like receptor 2 Human genes 0.000 claims 3
- 102100039360 Toll-like receptor 4 Human genes 0.000 claims 3
- 102100039357 Toll-like receptor 5 Human genes 0.000 claims 3
- 102100033117 Toll-like receptor 9 Human genes 0.000 claims 3
- 102100029681 Triggering receptor expressed on myeloid cells 1 Human genes 0.000 claims 3
- 102100040653 Tryptophan 2,3-dioxygenase Human genes 0.000 claims 3
- 101710136122 Tryptophan 2,3-dioxygenase Proteins 0.000 claims 3
- 102100036922 Tumor necrosis factor ligand superfamily member 13B Human genes 0.000 claims 3
- 101710181056 Tumor necrosis factor ligand superfamily member 13B Proteins 0.000 claims 3
- 102100035283 Tumor necrosis factor ligand superfamily member 18 Human genes 0.000 claims 3
- 102100026890 Tumor necrosis factor ligand superfamily member 4 Human genes 0.000 claims 3
- 102100032101 Tumor necrosis factor ligand superfamily member 9 Human genes 0.000 claims 3
- 102100029675 Tumor necrosis factor receptor superfamily member 13B Human genes 0.000 claims 3
- 102100029690 Tumor necrosis factor receptor superfamily member 13C Human genes 0.000 claims 3
- 102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 claims 3
- 102100033728 Tumor necrosis factor receptor superfamily member 18 Human genes 0.000 claims 3
- 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 claims 3
- 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 claims 3
- 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 claims 3
- 102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 claims 3
- 102100029823 Tyrosine-protein kinase BTK Human genes 0.000 claims 3
- 102100023345 Tyrosine-protein kinase ITK/TSK Human genes 0.000 claims 3
- 102100038929 V-set domain-containing T-cell activation inhibitor 1 Human genes 0.000 claims 3
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 claims 3
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 claims 3
- 201000007111 hereditary spastic paraplegia 64 Diseases 0.000 claims 3
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 claims 3
- 229940039781 leptin Drugs 0.000 claims 3
- 201000001278 lymphoproliferative syndrome 2 Diseases 0.000 claims 3
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 claims 3
- 102000039446 nucleic acids Human genes 0.000 claims 3
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 150000007523 nucleic acids Chemical class 0.000 claims 3
- 108020003175 receptors Proteins 0.000 claims 3
- 102000005962 receptors Human genes 0.000 claims 3
- 235000011178 triphosphate Nutrition 0.000 claims 3
- 239000001226 triphosphate Substances 0.000 claims 3
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 claims 3
- 101100166600 Homo sapiens CD28 gene Proteins 0.000 claims 2
- 101001042104 Homo sapiens Inducible T-cell costimulator Proteins 0.000 claims 2
- 101001076386 Homo sapiens Interleukin-1 family member 10 Proteins 0.000 claims 2
- 101001055219 Homo sapiens Interleukin-9 receptor Proteins 0.000 claims 2
- 108091058560 IL8 Proteins 0.000 claims 2
- 102100021317 Inducible T-cell costimulator Human genes 0.000 claims 2
- 102100026015 Interleukin-1 family member 10 Human genes 0.000 claims 2
- 102100026244 Interleukin-9 receptor Human genes 0.000 claims 2
- 102100024584 Tumor necrosis factor ligand superfamily member 12 Human genes 0.000 claims 2
- 101710097155 Tumor necrosis factor ligand superfamily member 12 Proteins 0.000 claims 2
- 239000013604 expression vector Substances 0.000 claims 2
- IJJVMEJXYNJXOJ-UHFFFAOYSA-N fluquinconazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1N1C(=O)C2=CC(F)=CC=C2N=C1N1C=NC=N1 IJJVMEJXYNJXOJ-UHFFFAOYSA-N 0.000 claims 2
- 208000027866 inflammatory disease Diseases 0.000 claims 2
- 108010080422 CD39 antigen Proteins 0.000 claims 1
- 102000004127 Cytokines Human genes 0.000 claims 1
- 108090000695 Cytokines Proteins 0.000 claims 1
- 241000238631 Hexapoda Species 0.000 claims 1
- 101001033249 Homo sapiens Interleukin-1 beta Proteins 0.000 claims 1
- 102100039065 Interleukin-1 beta Human genes 0.000 claims 1
- 102000018697 Membrane Proteins Human genes 0.000 claims 1
- 108010052285 Membrane Proteins Proteins 0.000 claims 1
- 102100025237 T-cell surface antigen CD2 Human genes 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 229940127089 cytotoxic agent Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 210000004962 mammalian cell Anatomy 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662322036P | 2016-04-13 | 2016-04-13 | |
| US62/322,036 | 2016-04-13 | ||
| US201662331191P | 2016-05-03 | 2016-05-03 | |
| US62/331,191 | 2016-05-03 | ||
| US201662412187P | 2016-10-24 | 2016-10-24 | |
| US62/412,187 | 2016-10-24 | ||
| EP17305298.6 | 2017-03-17 | ||
| EP17305298 | 2017-03-17 | ||
| PCT/US2017/027488 WO2017180913A2 (en) | 2016-04-13 | 2017-04-13 | Trispecific and/or trivalent binding proteins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019522459A JP2019522459A (ja) | 2019-08-15 |
| JP2019522459A5 true JP2019522459A5 (enExample) | 2020-05-07 |
| JP7195929B2 JP7195929B2 (ja) | 2022-12-26 |
Family
ID=58464471
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018554100A Active JP7195929B2 (ja) | 2016-04-13 | 2017-04-13 | 三重特異性および／または三価結合タンパク質 |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US10882922B2 (enExample) |
| EP (1) | EP3443006B1 (enExample) |
| JP (1) | JP7195929B2 (enExample) |
| KR (1) | KR20180134378A (enExample) |
| CN (1) | CN109476732B (enExample) |
| AU (1) | AU2017248671B2 (enExample) |
| BR (1) | BR112018070998A2 (enExample) |
| CA (1) | CA3020633A1 (enExample) |
| CL (1) | CL2018002883A1 (enExample) |
| CO (1) | CO2018012107A2 (enExample) |
| CR (1) | CR20180539A (enExample) |
| DO (1) | DOP2018000225A (enExample) |
| EA (1) | EA201892312A1 (enExample) |
| IL (1) | IL262241B2 (enExample) |
| MA (1) | MA44670B1 (enExample) |
| MX (1) | MX2018012566A (enExample) |
| PE (1) | PE20190128A1 (enExample) |
| PH (1) | PH12018502182A1 (enExample) |
| PT (1) | PT3443006T (enExample) |
| SG (1) | SG11201808911SA (enExample) |
| TW (1) | TWI788286B (enExample) |
| UY (1) | UY37206A (enExample) |
| WO (1) | WO2017180913A2 (enExample) |
Families Citing this family (77)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI743461B (zh) * | 2011-03-28 | 2021-10-21 | 法商賽諾菲公司 | 具有交叉結合區定向之雙重可變區類抗體結合蛋白 |
| CN120988137A (zh) * | 2015-01-23 | 2025-11-21 | 赛诺菲 | 抗cd3抗体、抗cd123抗体和与cd3和/或cd123特异性结合的双特异性抗体 |
| AR106188A1 (es) | 2015-10-01 | 2017-12-20 | Hoffmann La Roche | Anticuerpos anti-cd19 humano humanizados y métodos de utilización |
| RS62437B1 (sr) | 2015-10-25 | 2021-11-30 | Sanofi Sa | Trispecifični i/ili trivalentni vezujući proteini za prevenciju ili lečenje hiv infekcije |
| LT3443006T (lt) | 2016-04-13 | 2023-10-25 | Sanofi | Trispecifiniai ir (arba) trivalenčiai rišantieji baltymai |
| CA3020633A1 (en) | 2016-04-13 | 2017-10-19 | Sanofi | Trispecific and/or trivalent binding proteins |
| EP3448874A4 (en) | 2016-04-29 | 2020-04-22 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| WO2018151841A1 (en) | 2017-02-17 | 2018-08-23 | Sanofi | Multispecific binding molecules having specificity to dystroglycan and laminin-2 |
| KR102654105B1 (ko) | 2017-02-17 | 2024-04-04 | 사노피 | 디스트로글리칸 및 라미닌-2에 대한 특이성을 갖는 다중특이적 결합 분자 |
| DK3583126T3 (da) | 2017-02-17 | 2025-11-17 | Sanofi Sa | Multispecifikke bindingsmolekyler med specificitet for dystroglycan og laminin-2 |
| AU2018224094B2 (en) | 2017-02-24 | 2025-04-17 | Macrogenics, Inc. | Bispecific binding molecules that are capable of binding CD137 and tumor antigens, and uses thereof |
| UY37758A (es) * | 2017-06-12 | 2019-01-31 | Novartis Ag | Método de fabricación de anticuerpos biespecíficos, anticuerpos biespecíficos y uso terapéutico de dichos anticuerpos |
| BR112020007002A2 (pt) | 2017-10-10 | 2020-11-17 | Sanofi | anticorpos anti-cd38 e métodos de uso |
| MY205342A (en) * | 2017-11-01 | 2024-10-16 | Hoffmann La Roche | Bispecific 2+1 contorsbodies |
| EP3713959A1 (en) * | 2017-11-21 | 2020-09-30 | Innate Pharma | Multispecific antigen binding proteins |
| AU2018387829B2 (en) | 2017-12-22 | 2024-12-19 | Argenx Bvba | Bispecific antigen binding construct |
| CN109957026A (zh) * | 2017-12-22 | 2019-07-02 | 成都恩沐生物科技有限公司 | 共价多特异性抗体 |
| US12247060B2 (en) | 2018-01-09 | 2025-03-11 | Marengo Therapeutics, Inc. | Calreticulin binding constructs and engineered T cells for the treatment of diseases |
| CN119291194A (zh) * | 2018-01-12 | 2025-01-10 | 建新公司 | 用于定量多肽的方法 |
| JP7337079B2 (ja) | 2018-02-15 | 2023-09-01 | マクロジェニクス，インコーポレーテッド | 変異型ｃｄ３結合ドメイン、及び疾患の治療のための併用療法におけるその使用 |
| GB201802487D0 (en) | 2018-02-15 | 2018-04-04 | Argenx Bvba | Cytokine combination therapy |
| CA3089230A1 (en) * | 2018-03-02 | 2019-09-06 | Cdr-Life Ag | Trispecific antigen binding proteins |
| SG11202007055QA (en) * | 2018-03-08 | 2020-09-29 | Phanes Therapeutics Inc | Anti-claudin 18.2 antibodies and uses thereof |
| EP3765517A1 (en) | 2018-03-14 | 2021-01-20 | Elstar Therapeutics, Inc. | Multifunctional molecules that bind to calreticulin and uses thereof |
| EP3765516A2 (en) * | 2018-03-14 | 2021-01-20 | Elstar Therapeutics, Inc. | Multifunctional molecules and uses thereof |
| SG11202008474QA (en) * | 2018-03-27 | 2020-10-29 | Systimmune Inc | Guidance and navigation control proteins and method of making and using thereof |
| US10633458B2 (en) * | 2018-04-10 | 2020-04-28 | Y-Biologics Inc. | Cell engaging binding molecules |
| CN112384243A (zh) * | 2018-04-17 | 2021-02-19 | 英温拉公司 | 三价三特异性抗体构建体 |
| CN112912103B (zh) * | 2018-05-21 | 2025-08-29 | 广州邦定生物技术有限公司 | 多价蛋白质复合物 |
| CA3105448A1 (en) | 2018-07-03 | 2020-01-09 | Elstar Therapeutics, Inc. | Anti-tcr antibody molecules and uses thereof |
| EP3833392A4 (en) * | 2018-08-08 | 2022-05-18 | Dragonfly Therapeutics, Inc. | MULTISPECIFIC BINDING PROTEINS FOR BINDING CD33, NKG2D AND CD16 AND METHODS OF USE |
| CA3109513A1 (en) * | 2018-08-23 | 2020-02-27 | Regeneron Pharmaceuticals, Inc. | Anti-fc epsilon-r1 alpha (fcer1a) antibodies, bispecific antigen-binding molecules that bind fcer1a and cd3, and uses thereof |
| JP7462621B2 (ja) * | 2018-10-09 | 2024-04-05 | サノフイ | 三重特異性抗ｃｄ３８、抗ｃｄ２８、および抗ｃｄ３結合タンパク質ならびにウイルス感染を処置するための使用方法 |
| CN111153988B (zh) * | 2018-11-08 | 2022-11-04 | 中国科学院上海巴斯德研究所 | 广谱抗肠道病毒d68型的中和性单克隆抗体 |
| EP3674316A1 (en) | 2018-12-24 | 2020-07-01 | Sanofi | Multispecific binding proteins with mutant fab domains |
| AU2019412561A1 (en) | 2018-12-24 | 2021-08-12 | Sanofi | Multispecific binding proteins with mutant Fab domains |
| IL319262A (en) | 2018-12-24 | 2025-04-01 | Sanofi Sa | Multispecific FAB pseudoproteins bind |
| CN113646334B (zh) * | 2019-02-20 | 2025-09-16 | 国家儿童医院研究所 | 癌症靶向的、病毒编码的、可调节的t细胞（catvert）或nk细胞（catvern）接头 |
| GB2599228B (en) | 2019-02-21 | 2024-02-07 | Marengo Therapeutics Inc | Multifunctional molecules that bind to T cell related cancer cells and uses thereof |
| CN119039441A (zh) | 2019-02-21 | 2024-11-29 | 马伦戈治疗公司 | 与nkp30结合的抗体分子及其用途 |
| TW202104274A (zh) | 2019-04-09 | 2021-02-01 | 法商賽諾菲公司 | 用於治療ｈｉｖ感染之三特異性及／或三價結合蛋白 |
| EP3953388A1 (en) * | 2019-04-09 | 2022-02-16 | Sanofi | Trispecific binding proteins, methods, and uses thereof |
| US11613576B2 (en) | 2019-04-09 | 2023-03-28 | Sanofi | Trispecific binding proteins, methods, and uses thereof |
| CN116987197A (zh) * | 2019-06-20 | 2023-11-03 | 成都恩沐生物科技有限公司 | 共价多特异性抗体 |
| CA3147044A1 (en) * | 2019-07-11 | 2021-01-14 | Tavotek Biotherapeutics (Hong Kong) Limited | Agents that interfere with thymic stromal lymphopoietin (tslp)-receptor signaling |
| US20220112258A1 (en) * | 2019-07-25 | 2022-04-14 | I-Mab Biopharma Us Limited | Bifunctional molecules with il-7 activity |
| WO2021080649A1 (en) | 2019-10-25 | 2021-04-29 | Sanofi | Methods for analyzing chain mispairing in multispecific binding proteins |
| MX2022005330A (es) * | 2019-11-05 | 2022-05-26 | Regeneron Pharma | Moleculas de union multiespecificas con scfv en el extremo nterminal. |
| AU2020416273A1 (en) | 2020-01-03 | 2022-07-28 | Marengo Therapeutics, Inc. | Anti-TCR antibody molecules and uses thereof |
| US20230138520A1 (en) * | 2020-01-16 | 2023-05-04 | Caerus Therapeutics, Inc. | Humanized antibodies specific for myeloma and ovarian cancer cells |
| KR20220159989A (ko) | 2020-02-26 | 2022-12-05 | 바이오그래프 55, 인크. | C19 c38 이중특이적 항체 |
| TW202146463A (zh) | 2020-03-05 | 2021-12-16 | 法商賽諾菲公司 | 蛋白酶加工的分子 |
| JP2023519699A (ja) * | 2020-03-30 | 2023-05-12 | サノフイ | スプリットｃｈ２ドメイン |
| AU2021295549A1 (en) * | 2020-06-23 | 2022-11-24 | F. Hoffmann-La Roche Ag | Agonistic CD28 antigen binding molecules targeting Her2 |
| JP7620780B2 (ja) * | 2020-06-30 | 2025-01-24 | ノナ・バイオサイエンシーズ・（シャンハイ）・カンパニー・リミテッド | Ｈ２Ｌ２とＨＣＡｂ構造を有する結合タンパク質 |
| WO2022036495A1 (en) | 2020-08-17 | 2022-02-24 | Utc Therapeutics Inc. | Lymphocytes-antigen presenting cells co-stimulators and uses thereof |
| MX2023003214A (es) * | 2020-09-18 | 2023-05-24 | Regeneron Pharma | Moleculas de union al antigeno que se unen a cd38 y/o cd28 y usos de las mismas. |
| CN116648463A (zh) | 2020-09-18 | 2023-08-25 | 伊克诺斯科学公司 | Cd47-cd38双特异性抗体 |
| KR20230110291A (ko) | 2020-11-18 | 2023-07-21 | 노파르티스 아게 | Nlrc4-gof 염증복합체병증의 치료에 사용하기 위한 이중특이적 항체 |
| EP4347640A1 (en) | 2021-05-27 | 2024-04-10 | Sanofi | Fc variant with enhanced affinity to fc receptors and improved thermal stability |
| CN118251411A (zh) * | 2021-09-29 | 2024-06-25 | 摩德斯医疗股份有限公司 | 抗原结合多肽、抗原结合多肽复合物及其使用方法 |
| CA3232365A1 (en) * | 2021-09-29 | 2023-04-06 | Ronnie Rong Wei | Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereof in hiv |
| TW202330594A (zh) * | 2021-09-29 | 2023-08-01 | 美商莫德斯醫療公司 | 抗原結合多肽、抗原結合多肽複合物及其使用方法 |
| WO2023060277A1 (en) * | 2021-10-08 | 2023-04-13 | Arbele Limited | Composition of multispecific antibodies targeting cdh17-expressing tumors and method of making and using thereof |
| US20250381223A1 (en) * | 2022-02-16 | 2025-12-18 | Utc Therapeutics (Shanghai) Co., Ltd. | Humanized anti-cd28 antibody and bispecific antibody thereof with anti-cd40 antibody |
| US20240117030A1 (en) * | 2022-03-03 | 2024-04-11 | Pfizer Inc. | Multispecific antibodies and uses thereof |
| US20240228650A9 (en) | 2022-05-06 | 2024-07-11 | Ichnos Sciences SA | CD3/BCMA/CD38 Trispecific Antibodies |
| KR20250017240A (ko) | 2022-05-27 | 2025-02-04 | 사노피 | FC-조작을 갖는 NKp46 및 BCMA 변이체에 결합하는 자연 살해(NK) 세포 관여자 |
| EP4540284A2 (en) | 2022-06-17 | 2025-04-23 | Apogee Therapeutics, Inc. | Antibodies that bind interleukin 13 and methods of use |
| CN119487071A (zh) * | 2022-06-24 | 2025-02-18 | 北京可瑞生物科技有限公司 | 基于t细胞受体的双特异性多肽分子及其用途 |
| CN119923415A (zh) * | 2022-08-05 | 2025-05-02 | 成都恩沐生物科技有限公司 | 靶向可二聚化肿瘤抗原和免疫刺激性抗原的多特异性抗体 |
| EP4640700A1 (en) * | 2022-12-19 | 2025-10-29 | Harbour Biomed (Shanghai) Co., Ltd | "kappa/lambda" fab-fab series-connection multi-specific binding protein, preparation thereof, and use thereof |
| AU2024239150A1 (en) | 2023-03-21 | 2025-10-02 | Biograph 55, Inc. | Cd19/cd38 multispecific antibodies |
| WO2025006794A1 (en) * | 2023-06-29 | 2025-01-02 | Promab Biotechnologies, Inc. | Her-2 -cd3-epsilon bispecific antibodies |
| WO2025027003A1 (en) | 2023-07-31 | 2025-02-06 | Sanofi | Methods and uses for anti-cd38 t cell engagers in treatment of peripheral t-cell lymphomas |
| US20250376537A1 (en) | 2024-05-17 | 2025-12-11 | Sanofi | Methods of treating cancer using trispecific binding proteins targeting her2-expressing tumors |
| WO2026022712A1 (en) | 2024-07-23 | 2026-01-29 | Sanofi | Cereblon ligase modulator and bcma nk cell engager combination therapy |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3850542T2 (de) | 1987-09-23 | 1994-11-24 | Bristol Myers Squibb Co | Antikörper-Heterokonjugate zur Töting von HIV-infizierten Zellen. |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| ATE375365T1 (de) | 1998-04-02 | 2007-10-15 | Genentech Inc | Antikörper varianten und fragmente davon |
| RU2420537C2 (ru) * | 2001-01-17 | 2011-06-10 | Трабьон Фармасьютикалз Инк. | Слитые белки связывающий домен-иммуноглобулин |
| CN1294148C (zh) * | 2001-04-11 | 2007-01-10 | 中国科学院遗传与发育生物学研究所 | 环状单链三特异抗体 |
| NZ544924A (en) | 2003-06-27 | 2009-03-31 | Biogen Idec Inc | Modified binding molecules comprising connecting peptides |
| US9200061B2 (en) | 2004-02-06 | 2015-12-01 | Morpho Sys AG | Generation and profiling of fully human HuCAL gold®-derived therapeutic antibodies specific for human CD3i |
| CN100376599C (zh) | 2004-04-01 | 2008-03-26 | 北京安波特基因工程技术有限公司 | 基因工程重组抗cea抗cd3抗cd28线性单链三特异抗体 |
| EP2050764A1 (en) | 2007-10-15 | 2009-04-22 | sanofi-aventis | Novel polyvalent bispecific antibody format and uses thereof |
| CA2726087A1 (en) | 2008-06-03 | 2009-12-10 | Tariq Ghayur | Dual variable domain immunoglobulins and uses thereof |
| CA2774636C (en) | 2009-09-25 | 2019-05-21 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Neutralizing antibodies to hiv-1 and their use |
| SMT202000031T1 (it) * | 2010-06-09 | 2020-03-13 | Genmab As | Anticorpi contro cd38 umano |
| JOP20210044A1 (ar) | 2010-12-30 | 2017-06-16 | Takeda Pharmaceuticals Co | الأجسام المضادة لـ cd38 |
| TWI743461B (zh) | 2011-03-28 | 2021-10-21 | 法商賽諾菲公司 | 具有交叉結合區定向之雙重可變區類抗體結合蛋白 |
| WO2012154312A1 (en) | 2011-05-09 | 2012-11-15 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Neutralizing antibodies to hiv-1 and their use |
| WO2012158818A2 (en) * | 2011-05-16 | 2012-11-22 | Fabion Pharmaceuticals, Inc. | Multi-specific fab fusion proteins and methods of use |
| CN103797029B (zh) | 2011-05-17 | 2016-08-17 | 洛克菲勒大学 | 人类免疫缺陷病毒中和抗体及其使用方法 |
| BR112014010823B1 (pt) | 2011-11-07 | 2021-02-17 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | anticorpos que se ligam a gp41 e neutralizam o vírus da imunodeficiência humana tipo 1 (hiv-1), seus usos, molécula de ácido nucleico, vetor de expressão, composição, kit, bem como métodos de detecção de infecção pelo hiv-1 e de teste de imunógeno potencial |
| EP2788376B1 (en) | 2011-12-08 | 2018-10-03 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Neutralizing antibodies to hiv-1 and their use |
| WO2013163427A1 (en) | 2012-04-25 | 2013-10-31 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Antibodies to treat hiv-1 infection |
| JOP20200236A1 (ar) | 2012-09-21 | 2017-06-16 | Regeneron Pharma | الأجسام المضادة لمضاد cd3 وجزيئات ربط الأنتيجين ثنائية التحديد التي تربط cd3 وcd20 واستخداماتها |
| AU2013322710A1 (en) * | 2012-09-25 | 2015-04-16 | Glenmark Pharmaceuticals S.A. | Purification of hetero-dimeric immunoglobulins |
| US20140213772A1 (en) * | 2012-12-28 | 2014-07-31 | Abbvie, Inc. | Cross-over dual variable domain immunoglobulin constructs |
| US10487155B2 (en) | 2013-01-14 | 2019-11-26 | Xencor, Inc. | Heterodimeric proteins |
| WO2014116846A2 (en) * | 2013-01-23 | 2014-07-31 | Abbvie, Inc. | Methods and compositions for modulating an immune response |
| LT2961771T (lt) | 2013-02-26 | 2020-03-10 | Roche Glycart Ag | Bispecifinės t ląstelę aktyvinančios antigeną surišančios molekulės, specifinės cd3 ir cea antigenams |
| US20140302037A1 (en) * | 2013-03-15 | 2014-10-09 | Amgen Inc. | BISPECIFIC-Fc MOLECULES |
| CN105209491A (zh) | 2013-03-15 | 2015-12-30 | 艾伯维公司 | 针对TNFα的双重特异性结合蛋白 |
| JP2016538275A (ja) | 2013-11-04 | 2016-12-08 | グレンマーク ファーマシューティカルズ， エセ．アー． | Ｔ細胞再標的化ヘテロ二量体免疫グロブリン（ｈｅｔｅｒｏ−ｄｉｍｅｒｉｃ ｉｍｍｕｎｏｇｌｏｂｕｌｉｎ）の製造 |
| EP3699195A3 (en) | 2014-03-28 | 2020-11-04 | Xencor, Inc. | Bispecific antibodies that bind to cd38 and cd3 |
| CN106687584B (zh) | 2014-09-04 | 2021-08-13 | 干细胞技术公司 | 用于t细胞或nk细胞活化和扩增的可溶性抗体复合物 |
| CN120988137A (zh) | 2015-01-23 | 2025-11-21 | 赛诺菲 | 抗cd3抗体、抗cd123抗体和与cd3和/或cd123特异性结合的双特异性抗体 |
| WO2016196740A1 (en) | 2015-06-02 | 2016-12-08 | The Rockefeller University | Tri-specific antibodies for hiv therapy |
| MX2018003463A (es) | 2015-09-22 | 2018-09-06 | Univ Pennsylvania | Método de redireccionamiento de células t para tratar la infección por virus de inmunodeficiencia humana (vih). |
| RS62437B1 (sr) | 2015-10-25 | 2021-11-30 | Sanofi Sa | Trispecifični i/ili trivalentni vezujući proteini za prevenciju ili lečenje hiv infekcije |
| CN105837688B (zh) | 2015-11-20 | 2019-02-26 | 北京大学深圳研究生院 | 单域抗体及其编码基因，免疫毒素及其编码基因、制备方法、表达载体、应用，及宿主细胞 |
| JP6732915B2 (ja) | 2015-12-15 | 2020-07-29 | ギリアード サイエンシーズ， インコーポレイテッド | ヒト免疫不全ウイルス中和抗体 |
| CA3020633A1 (en) | 2016-04-13 | 2017-10-19 | Sanofi | Trispecific and/or trivalent binding proteins |
| WO2018120842A1 (zh) | 2016-12-30 | 2018-07-05 | 上海欣百诺生物科技有限公司 | 一种双功能分子及其应用 |
| WO2018151841A1 (en) | 2017-02-17 | 2018-08-23 | Sanofi | Multispecific binding molecules having specificity to dystroglycan and laminin-2 |
| KR102654105B1 (ko) | 2017-02-17 | 2024-04-04 | 사노피 | 디스트로글리칸 및 라미닌-2에 대한 특이성을 갖는 다중특이적 결합 분자 |
| BR112020007002A2 (pt) | 2017-10-10 | 2020-11-17 | Sanofi | anticorpos anti-cd38 e métodos de uso |
| JP7462621B2 (ja) | 2018-10-09 | 2024-04-05 | サノフイ | 三重特異性抗ｃｄ３８、抗ｃｄ２８、および抗ｃｄ３結合タンパク質ならびにウイルス感染を処置するための使用方法 |
| US11613576B2 (en) | 2019-04-09 | 2023-03-28 | Sanofi | Trispecific binding proteins, methods, and uses thereof |
-
2017
- 2017-04-13 CA CA3020633A patent/CA3020633A1/en active Pending
- 2017-04-13 PE PE2018001987A patent/PE20190128A1/es unknown
- 2017-04-13 BR BR112018070998-0A patent/BR112018070998A2/pt not_active Application Discontinuation
- 2017-04-13 TW TW106112360A patent/TWI788286B/zh active
- 2017-04-13 JP JP2018554100A patent/JP7195929B2/ja active Active
- 2017-04-13 MX MX2018012566A patent/MX2018012566A/es unknown
- 2017-04-13 SG SG11201808911SA patent/SG11201808911SA/en unknown
- 2017-04-13 PT PT177322633T patent/PT3443006T/pt unknown
- 2017-04-13 EP EP17732263.3A patent/EP3443006B1/en active Active
- 2017-04-13 US US15/487,243 patent/US10882922B2/en active Active
- 2017-04-13 WO PCT/US2017/027488 patent/WO2017180913A2/en not_active Ceased
- 2017-04-13 KR KR1020187032530A patent/KR20180134378A/ko not_active Ceased
- 2017-04-13 AU AU2017248671A patent/AU2017248671B2/en active Active
- 2017-04-13 MA MA44670A patent/MA44670B1/fr unknown
- 2017-04-13 IL IL262241A patent/IL262241B2/en unknown
- 2017-04-13 CR CR20180539A patent/CR20180539A/es unknown
- 2017-04-13 CN CN201780036515.9A patent/CN109476732B/zh active Active
- 2017-04-13 EA EA201892312A patent/EA201892312A1/ru unknown
- 2017-04-18 UY UY0001037206A patent/UY37206A/es not_active Application Discontinuation
-
2018
- 2018-10-10 CL CL2018002883A patent/CL2018002883A1/es unknown
- 2018-10-11 PH PH12018502182A patent/PH12018502182A1/en unknown
- 2018-10-12 DO DO2018000225A patent/DOP2018000225A/es unknown
- 2018-11-09 CO CONC2018/0012107A patent/CO2018012107A2/es unknown
-
2020
- 2020-11-16 US US17/099,439 patent/US11192960B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019522459A5 (enExample) | ||
| US11192960B2 (en) | Trispecific and/or trivalent binding proteins | |
| US20120201746A1 (en) | Half immunoglobulin binding proteins and uses thereof | |
| IL261673A (en) | Protein-like binding proteins with a double variable region have a cross-linking region direction | |
| US20120195900A1 (en) | Tri-variable domain binding proteins and uses thereof | |
| US20090215992A1 (en) | Dual variable domain immunoglobulin and uses thereof | |
| US20110318349A1 (en) | Dual variable domain immunoglobulins and uses thereof | |
| WO2008024188A2 (en) | Dual variable domain immunoglobulin and uses thereof | |
| US11932704B2 (en) | Trispecific and/or trivalent binding proteins | |
| JP2025503480A5 (enExample) | ||
| RU2023128356A (ru) | Антитела к cd38 и комбинации с антителами к cd3 и сd28 | |
| RU2024102366A (ru) | Антитела к cd38 и комбинации с антителами к cd3 и сd28 | |
| RU2020115450A (ru) | Антитела к cd38 и комбинации с антителами к cd3 и cd28 | |
| HK40101445A (en) | Trispecific and/or trivalent binding proteins | |
| HK1260494A1 (en) | Trispecific and/or trivalent binding proteins | |
| HK1260494B (en) | Trispecific and/or trivalent binding proteins | |
| BR122024005246A2 (pt) | Método de purificação de uma proteína de ligação produzida por uma célula hospedeira |